A share price of Dexcom Inc [DXCM] is currently trading at $67.78, up 2.65%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The DXCM shares have gain 2.57% over the last week, with a monthly amount drifted -13.55%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Dexcom Inc [NASDAQ: DXCM] stock has seen the most recent analyst activity on September 08, 2025, when Oppenheimer downgraded its rating to a Perform. Previously, Argus started tracking the stock with Buy rating on August 21, 2025, and set its price target to $100. On June 16, 2025, Truist initiated with a Buy rating and assigned a price target of $102 on the stock. Goldman started tracking the stock assigning a Buy rating and suggested a price target of $104 on May 30, 2025. Mizuho initiated its recommendation with a Outperform and recommended $85 as its price target on April 10, 2025. Redburn Atlantic upgraded its rating to Buy for this stock on February 03, 2025, and upped its price target to $115. In a note dated January 16, 2025, Robert W. Baird upgraded an Outperform rating on this stock and boosted its target price from $86 to $104.
Dexcom Inc experienced fluctuations in its stock price throughout the past year between $57.52 and $93.25. Currently, Wall Street analysts expect the stock to reach $90 within the next 12 months. Dexcom Inc [NASDAQ: DXCM] shares were valued at $67.78 at the most recent close of the market. An investor can expect a potential return of 32.78% based on the average DXCM price forecast.
Analyzing the DXCM fundamentals
Trailing Twelve Months sales for Dexcom Inc [NASDAQ:DXCM] were 4.30B which represents 15.21% growth. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.18%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.26 and Total Capital is 0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 65.83 points at the first support level, and at 63.87 for the second support level. However, for the 1st resistance point, the stock is sitting at 68.81, and for the 2nd resistance point, it is at 69.83.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Dexcom Inc [NASDAQ:DXCM] is 1.52. In addition, the Quick Ratio stands at 1.35 and the Cash Ratio stands at 0.35. Considering the valuation of this stock, the price to sales ratio is 6.18, the price to book ratio is 10.33 and price to earnings (TTM) ratio is 47.45.
Transactions by insiders
Recent insider trading involved Malady Kyle, Director, that happened on Sep 05 ’25 when 667.0 shares were sold. EVP, Chief HR Officer, Stern Sadie completed a deal on Sep 04 ’25 to sell 1466.0 shares. Meanwhile, Director Malady Kyle bought 667.0 shares on Sep 05 ’25.
